Testing effectiveness (Phase 2)Looking for participantsNCT07053462
What this trial is testing
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
Who this might be right for
End-Stage Renal DiseaseEnd Stage Renal Disease on DialysisEnd Stage Renal Disease With Renal Transplant+4 more
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90